The Michael Mason prize: development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine.

ABSTRACT:

Objectives

Only 12% of people recommended fracture prevention medicines remain on treatment 1 year post fracture. The 'improving uptake of Fracture Prevention treatments' (iFraP) intervention aims to improve shared decision-making (SDM) about, and uptake of, osteoporosis medicines in Fracture Liaison Services (FLS). This paper details development and feasibility.

Methods

Intervention development was underpinned by (i) theories of SDM, medicines adherence and behaviour change; (ii) integrated findings from seven development studies; and (iii) extensive patient and clinician contribution, identifying key 'needs' to address and the intervention's content, functionality and scope. Feasibility testing was conducted at one English FLS. Intervention consultations were observed and

SUBMITTER: Bullock L 

PROVIDER: S-EPMC12862368 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature